{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:06:42Z","timestamp":1788275202332,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["BR24992814"],"award-info":[{"award-number":["BR24992814"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Metabolic syndrome is a common condition associated with a higher risk of diabetes and cardiovascular disease. Altered iron metabolism, especially iron overload, may play a role in the development of insulin resistance, hypertension, and other metabolic abnormalities. Although the p.C282Y polymorphism of the HFE gene affects iron regulation and may contribute to these metabolic changes, previous studies have reported inconsistent findings, thus highlighting the need for a comprehensive meta-analysis. Materials and Methods: A systematic literature search was performed in PubMed, Scopus, and Web of Science to examine the associations between the HFE p.C282Y polymorphism and components of metabolic syndrome. Observational studies were included if they compared the frequencies of diabetes, hypertension, and abdominal obesity, as well as levels of triglycerides and high-density lipoprotein cholesterol, between carriers and non-carriers of the p.C282Y variant. Results: A total of 17 studies were included in the meta-analysis, and the pooled analysis demonstrated no significant association between the HFE p.C282Y polymorphism and diabetes, hypertension, triglyceride levels, or HDL cholesterol levels under the codominant model. Similarly, analyses performed using the homozygous model did not reveal any statistically significant associations. Conclusions: This meta-analysis found no statistically significant association between the HFE p.C282Y polymorphism and any of the considered components of metabolic syndrome under the examined genetic models.<\/jats:p>","DOI":"10.3390\/medicina62030589","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:07:06Z","timestamp":1774271226000},"page":"589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HFE p.C282Y Polymorphism and Risk of Metabolic Syndrome Components: Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"62","author":[{"given":"Dana","family":"Kaldarkhan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-3221","authenticated-orcid":false,"given":"Gulnaz","family":"Nuskabayeva","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-7211","authenticated-orcid":false,"given":"Nursultan","family":"Nurdinov","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-5209","authenticated-orcid":false,"given":"Yerbolat","family":"Saruarov","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-479X","authenticated-orcid":false,"given":"Ugilzhan","family":"Tatykayeva","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5655-5465","authenticated-orcid":false,"given":"Ainash","family":"Oshibayeva","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-8565","authenticated-orcid":false,"given":"Karlygash","family":"Sadykova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 160000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rizvi, A.A., Stoian, A.P., and Rizzo, M. (2021). Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810038"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","article-title":"Mitochondrial dysfunction in metabolic syndrome","volume":"1866","author":"Prasun","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2174\/1381612826666200130090703","article-title":"Dysmetabolic Iron Overload in Metabolic Syndrome","volume":"26","author":"Sachinidis","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41574-023-00807-6","article-title":"Consensus Statement on the definition and classification of metabolic hyperferritinaemia","volume":"19","author":"Valenti","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/1381612826666200131103018","article-title":"Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?","volume":"26","author":"Rametta","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1182\/bloodadvances.2024013666","article-title":"Impact of iron overload on incidence of diabetes mellitus, cardiac disease, and death in congenital hemolytic anemias","volume":"8","author":"Cheng","year":"2024","journal-title":"Blood Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e4641","DOI":"10.1210\/clinem\/dgab454","article-title":"Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study","volume":"106","author":"Wang","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(23)00287-8","article-title":"Haemochromatosis","volume":"401","author":"Adams","year":"2023","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Piesanen, J., Valjakka, J., Niemel\u00e4, S., Borgenstr\u00f6m, M., Nikkari, S., Hyt\u00f6nen, V., M\u00e4\u00e4tt\u00e4, J., and Kunnas, T. (2022). Hepcidin is potential regulator for renin activity. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0267343"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2013.02.007","article-title":"Iron and diabetes risk","volume":"17","author":"Simcox","year":"2013","journal-title":"Cell Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-physiol-022522-102832","article-title":"Iron and the Pathophysiology of Diabetes","volume":"85","author":"Harrison","year":"2023","journal-title":"Annu. Rev. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e079147","DOI":"10.1136\/bmj-2023-079147","article-title":"Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: Prospective cohort study","volume":"387","author":"Mottelson","year":"2024","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.trsl.2008.05.005","article-title":"HFE C282Y homozygotes have reduced LDL cholesterol: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"152","author":"Pankow","year":"2008","journal-title":"Transl. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2796.2003.01094.x","article-title":"A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis","volume":"253","author":"Cadet","year":"2003","journal-title":"J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21742","article-title":"HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis","volume":"46","author":"Nelson","year":"2007","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"k5222","DOI":"10.1136\/bmj.k5222","article-title":"Common conditions associated with hereditary haemochromatosis genetic variants: Cohort study in UK Biobank","volume":"364","author":"Pilling","year":"2019","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1530\/eje.1.02152","article-title":"Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department","volume":"154","author":"Vantyghem","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1289\/ehp.1002251","article-title":"HFE H63D Polymorphism as a Modifier of the Effect of Cumulative Lead Exposure on Pulse Pressure: The Normative Aging Study","volume":"118","author":"Zhang","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e000278","DOI":"10.1136\/bmjdrc-2016-000278","article-title":"Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS Study","volume":"4","author":"Barton","year":"2016","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0021-9150(00)00623-7","article-title":"A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: The Atherosclerosis Risk in Communities (ARIC) study","volume":"154","author":"Rasmussen","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2141.1998.01067.x","article-title":"The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated","volume":"103","author":"Solinas","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-2002-33071","article-title":"Relations among serum ferritin, C282Y and H63D mutations in the HFE gene and type 2 diabetes mellitus in the Czech population","volume":"110","author":"Jansen","year":"2002","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2796.2010.02217.x","article-title":"Haemochromatosis genotype and iron overload: Association with hypertension and left ventricular hypertrophy","volume":"268","author":"Ellervik","year":"2010","journal-title":"J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"M\u00f8ller, D.V., Pecini, R., Gustafsson, F., Hassager, C., Hedley, P., Jespersgaard, C., Torp-Pedersen, C., Christiansen, M., and K\u00f8ber, L.V. (2010). Hereditary Hemochromatosis (HFE) genotypes in heart failure: Relation to etiology and prognosis. BMC Med. Genet., 11.","DOI":"10.1186\/1471-2350-11-117"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2337\/dc08-0248","article-title":"Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes","volume":"31","author":"Davis","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/HEP.0000000000001056","article-title":"Incidence of liver complications with hemochromatosis-associated HFE p.C282Y homozygosity: The role of central adiposity","volume":"81","author":"Lucas","year":"2025","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2005.05.027","article-title":"Phenotypic expression in detected C282Y homozygous women depends on body mass index","volume":"43","author":"Jouannolle","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/aje\/kws126","article-title":"Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: A meta-analysis","volume":"176","author":"Rong","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG Clinical Guideline: Hereditary Hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2337\/dc13-0713","article-title":"Diabetes in first-degree family members: A predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity","volume":"37","author":"Barton","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9826930","DOI":"10.1155\/2017\/9826930","article-title":"Diabetes in HFE Hemochromatosis","volume":"2017","author":"Barton","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/jhg.2012.25","article-title":"Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: A case-control study in Han Chinese","volume":"57","author":"Lu","year":"2012","journal-title":"J. Hum. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMra2119758","article-title":"Hemochromatosis","volume":"387","author":"Olynyk","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1001\/jama.2020.21566","article-title":"Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy","volume":"324","author":"Atkins","year":"2020","journal-title":"JAMA"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:40:49Z","timestamp":1774273249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["medicina62030589"],"URL":"https:\/\/doi.org\/10.3390\/medicina62030589","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}